Fate Therapeutics' Upcoming Conference Participation
Fate Therapeutics, Inc. (NASDAQ: FATE), a pioneering clinical-stage biopharmaceutical company, is making strides in developing innovative induced pluripotent stem cell (iPSC)-derived cellular immunotherapies designed for patients battling cancer and autoimmune diseases. The company is set to showcase its advancements at the Piper Sandler 37th Annual Healthcare Conference.
Details of the Presentation
During this prestigious event, Fate Therapeutics will engage in significant discussions. Company management is poised to participate in a fireside chat scheduled for 9:00 AM ET, followed by a cell therapy panel discussion at noon. This is an exciting opportunity for the company to present insights into its unique iPSC product platform, which is leading the way in clinical innovation.
Live Webcast Access
Those interested will have the chance to access a live webcast of the presentations. These will be made available in the “Events & Presentations” section on the company’s website. The archived versions of the sessions are expected to be accessible shortly after the event concludes.
About Fate Therapeutics
Fate Therapeutics stands out as a leader in the biopharmaceutical sector due to its commitment to pioneering iPSC-derived therapeutics. The company's cutting-edge research centers on creating an array of multiplexed-engineered master iPSC lines, broadening the horizon for off-the-shelf cell products tailored to patient needs. Their diverse pipeline features iPSC-derived natural killer (NK) and T-cell product candidates that are revolutionizing patient care.
Innovative Therapeutic Approaches
With a focus on utilizing novel synthetic control mechanisms for cell function, Fate Therapeutics is uniquely positioned to explore multiple therapeutic strategies. Each designed product aims to function seamlessly in delivering targeted therapeutic mechanisms that could potentially change patient outcomes.
Company Headquarters and Contact Information
Fate Therapeutics’ operational headquarters is situated in San Diego, CA. For those seeking more in-depth information about the company’s projects or product pipelines, their website serves as a comprehensive resource. Interested parties can easily navigate to various sections for the latest updates.
Contact:
Christina Tartaglia
Precision AQ
212.362.1200
christina.tartaglia@precisionaq.com
Frequently Asked Questions
What is Fate Therapeutics known for?
Fate Therapeutics specializes in the development of iPSC-derived cellular immunotherapies aimed at treating cancer and autoimmune diseases.
When and where will Fate Therapeutics be presenting?
Fate Therapeutics is scheduled to present at the Piper Sandler 37th Annual Healthcare Conference on December 2, focusing on their innovative therapies.
How can I access the presentation?
A live webcast of the presentation can be accessed through the Events section on the Fate Therapeutics website.
What is the significance of the iPSC technology used by Fate Therapeutics?
iPSC technology allows for the creation of versatile and scalable cell therapies that can be designed to meet various patient needs, offering potential breakthroughs in treatment.
Who can I contact for more information about Fate Therapeutics?
For inquiries, you can contact Christina Tartaglia at Precision AQ via phone at 212.362.1200 or email at christina.tartaglia@precisionaq.com.